Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TLR4 | O00206 | 4/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL685482 | 1.00 | TSHR (0.38) | TSHRMAPK1CES2MAPTTLR4 | |
| SCHEMBL2388827 | 1.00 | TSHR (0.38) | TSHRMAPK1CES2MAPTTLR4 | |
| SCHEMBL10008216 | 1.00 | TSHR (0.38) | TSHRMAPK1CES2MAPTTLR4 | |
| Phenylhydrazine SCHEMBL3087254 | 0.79 | CYP1A2 (0.40) | TDP1 | |
| SCHEMBL14099602 | 0.78 | MAPT (0.34) | MAPTTLR4 | |
| SCHEMBL1719695 | 0.74 | TSHR (0.43) | TSHRMAPK1KDM4EHTTTDP1 | |
| Beta-Pinene SCHEMBL900792 | 0.73 | TSHR (0.38) | TSHRMAPK1KDM4EHTTTDP1 | |
| (+)-Beta-Pinene SCHEMBL3506800 | 0.73 | TSHR (0.38) | TSHRMAPK1KDM4EHTTTDP1 | |
| Beta-Pinene SCHEMBL1636093 | 0.73 | TSHR (0.38) | TSHRMAPK1KDM4EHTTTDP1 | |
| Beta-Pinene SCHEMBL1532504 | 0.73 | TSHR (0.38) | TSHRMAPK1KDM4EHTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 422 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12458918-B2 | Process and apparatus for treating methane-containing gas | KANADEVIA INOVA AG (CH) | 2025-11-04 | — | — | US | claimed |
| US-20250262588-A1 | PROCESS AND APPARATUS FOR TREATING METHANE-CONTAINING GAS | KANADEVIA INOVA AG (CH) | 2025-08-21 | — | — | US | claimed |
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| EP-4536380-A1 | PROCESS AND APPARATUS FOR TREATING METHANE-CONTAINING GAS | Kanadevia Inova AG (CH) | 2025-04-16 | — | — | EP | claimed |
| CN-118754859-A | Nopinone tetrahydroquinazolinamine compound, preparation method and application | 西北农林科技大学 | 2024-10-11 | — | — | CN | claimed |
| CN-115260182-B | Thiazole coupling quinolyl phenol benzenesulfonate enhanced fluorescent probe for detecting hydrogen sulfide and preparation method and application thereof | 南京林业大学 | 2024-04-19 | — | — | CN | claimed |
| CN-115611818-B | Pyrimidine amine compound containing bicyclo-monoterpene structure, and preparation method and application thereof | 江苏医药职业学院 | 2024-03-29 | — | — | CN | claimed |
| WO-2023237568-A1 | PROCESS AND APPARATUS FOR TREATING METHANE-CONTAINING GAS | HITACHI ZOSEN INOVA AG (CH) | 2023-12-14 | — | — | WO | claimed |
| EP-4289498-A1 | METHOD AND DEVICE FOR THE TREATMENT OF GAS CONTAINING METHANE | Hitachi Zosen Inova AG (CH) | 2023-12-13 | — | — | EP | claimed |
| EP-1868979-A1 | EFFICIENT AND ECONOMIC ASYMMETRIC SYNTHESIS OF NOOTKATONE, TETRAHYDRONOOTKATONE, THEIR PRECURSORS AND DERIVATIVES | Board of Supervisors of Louisiana State University and Agricultural and Mechanical College (US) | 2007-12-26 | — | — | EP | claimed |
| WO-2007110548-A1 | PROCESS FOR DIASTEREOSELECTIVE ALKYLATION OF THE OXIME ETHER OF THE COMPOUND NOPINONE, AND NEW INTERMEDIATES FOR THE SYNTHESIS OF DIASTEREOSPECIFIC 2-AMINO-NOPINONE DERIVATIVES SUBSTITUTED ON THE 3 CARBON | PPG-SIPSY (FR) | 2007-10-04 | — | — | WO | claimed |
| US-20070225516-A1 | Process for the diastereoselective alkylation of an ether oxime of the compound nopinone and novel intermediates for the synthesis of diastereospecific 2-amino-nopinone derivatives substituted on carbon 3 | PPG-SIPSY (FR) | 2007-09-27 | — | — | US | claimed |
| WO-2006113285-A1 | EFFICIENT AND ECONOMIC ASYMMETRIC SYNTHESIS OF NOOTKATONE, TETRAHYDRONOOTKATONE, THEIR PRECURSORS AND DERIVATIVES | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2006-10-26 | — | — | WO | claimed |
| US-20060235247-A1 | EFFICIENT AND ECONOMIC ASYMMETRIC SYNTHESIS OF NOOTKATONE, TETRAHYDRONOOTKATONE, THEIR PRECURSORS AND DERIVATIVES | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE | 2006-10-19 | — | — | US | claimed |
| US-7112700-B1 | Efficient and economic asymmetric synthesis of nootkatone, tetrahydronootkatone, their precursors and derivatives | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2006-09-26 | — | — | US | claimed |
| EP-0754445-B1 | Photostable cosmetic light screening compositions | HOFFMANN LA ROCHE (CH) | 2001-10-24 | — | — | EP | claimed |
| US-5840282-A | SUNSCREEN AGENTS; BENZYLIDENE-TYPE STABILIZER | GIVAUDAN-ROURE (INTERNATIONAL) SA (CH) | 1998-11-24 | — | — | US | claimed |
| EP-0754445-A2 | Photostable cosmetic light screening compositions | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1997-01-22 | — | — | EP | claimed |
| EP-0034738-B1 | PROCESS FOR THE CONTINUOUS OZONOLYSIS OF BETA-PINENES | Henkel Kommanditgesellschaft auf Aktien (DE) | 1985-05-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060235247-A1 | EFFICIENT AND ECONOMIC ASYMMETRIC SYNTHESIS OF NOOTKATONE, TETRAHYDRONOOTKATONE, THEIR PRECURSORS AND DERIVATIVES | COASY, CYP51A1, ADRB2 | TSHR 3672/4885MAPK1 3374/4885CES2 675/4885 |
| US-20070225516-A1 | Process for the diastereoselective alkylation of an ether oxime of the compound nopinone and novel intermediates for the synthesis of diastereospecific 2-amino-nopinone derivatives substituted on carbon 3 | NOP2, NOP10, NOP56 | TSHR 2265/4885MAPK1 1758/4885CES2 1669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.